Organovo Holdings, Inc. announced that Barry Michaels, chief financial officer will retire after the end of the company's current fiscal year. Michaels, whose outstanding career spans over 40 years, has served as CFO of the company since August 2011.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5875 USD | -5.24% |
|
-17.83% | -47.07% |
05-31 | Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-15 | Organovo's fatty liver disease drug meets main goal in mid-stage study | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.07% | 8.91M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- Barry Michaels to Retire as Organovo Holdings's Chief Financial Officer